Domain Surgical, a Salt Lake City, Utah-based developer of advanced thermal surgical technology, closed a $35m equity and debt financing.
The round included a strategic leader in global medical technology and OrbiMed. Additional participants included BioStar Ventures, existing investors, board members and management.
The company intends to use the funds to evolve its ferromagnetic surgical product platform, produce additional outcomes evidence, and expand global sales and distribution.
Led by David McNally, President and CEO, Domain Surgical has commercialized a surgical platform for precise cutting and coagulation of soft tissue. Its patented technology produces surface-only tissue effects without passing electrical energy through the patient.